Simplex Trading’s Cytosorbents Corp CTSO Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2022
Q4
Sell
-1,300
Closed -$1K 9374
2022
Q3
$1K Buy
1,300
+300
+30% +$586 ﹤0.01% 9502
2022
Q2
$2K Buy
+1,000
New +$2.3K ﹤0.01% 9316
2021
Q4
Sell
-33,100
Closed -$249K 10601
2021
Q3
$249K Hold
33,100
﹤0.01% 5238
2021
Q2
$249K Buy
33,100
+32,695
+8,073% +$275K ﹤0.01% 5312
2021
Q1
$351K Buy
405
+336
+487% +$3.2K ﹤0.01% 3925
2020
Q4
$54K Sell
69
-131
-66% -$1.1K ﹤0.01% 6081
2020
Q3
$159K Buy
200
+54
+37% +$487 ﹤0.01% 4380
2020
Q2
$144K Sell
146
-55
-27% -$505 ﹤0.01% 4389
2020
Q1
$155K Buy
201
+187
+1,336% +$944 ﹤0.01% 3883
2019
Q4
$5K Hold
14
﹤0.01% 6682
2019
Q3
$7K Sell
14
-16
-53% -$93 ﹤0.01% 6435
2019
Q2
$19K Buy
30
+21
+233% +$144 ﹤0.01% 5629
2019
Q1
$6K Buy
9
+4
+80% +$31 ﹤0.01% 6400
2018
Q4
$4K Sell
5
-23
-82% -$228 ﹤0.01% 6294
2018
Q3
$36K Buy
28
+6
+27% +$75 ﹤0.01% 5467
2018
Q2
$25K Buy
+22
New +$208 ﹤0.01% 5680
2018
Q1
Sell
-47
Closed -$1K 6254
2017
Q4
$1K Sell
47
-32
-41% -$204 ﹤0.01% 5464
2017
Q3
$3K Buy
+79
New +$403 ﹤0.01% 4750
2017
Q2
Sell
-113
Closed -$6K 6194
2017
Q1
$6K Buy
+113
New +$631 ﹤0.01% 4410
2015
Q4
Sell
-11
Closed -$4K 5496
2015
Q3
$4K Buy
11
+3
+38% +$20 ﹤0.01% 4131
2015
Q2
$1K Buy
+8
New +$54 ﹤0.01% 4600

Other funds holding CTSO

Simplex Trading's CTSO Position: Q3 2025 in Review

Simplex Trading sold out of Cytosorbents Corp (CTSO) in Q3 2025, closing a stake of 100 shares.

Simplex Trading first reported a position in CTSO in Q1 2015 and held it in 31 quarters. The position peaked at $158K in Q2 2018. 49 funds tracked by Wall St. Rank hold CTSO as of Q3 2025.

  • Simplex Trading reported no remaining Cytosorbents Corp position as of Q3 2025 after selling out during the quarter.
  • Simplex Trading sold 100 Cytosorbents Corp shares in Q3 2025.
  • Simplex Trading first reported a position in Cytosorbents Corp in Q1 2015 and held it in 31 quarters.
  • Simplex Trading's Cytosorbents Corp position peaked at $158K in Q2 2018.
  • 49 funds tracked by Wall St. Rank held Cytosorbents Corp as of Q3 2025.

Based on Simplex Trading's 13F filing for Q3 2025, filed 12 Nov 2025.